Viewing StudyNCT01288209



Ignite Creation Date: 2024-05-05 @ 11:13 PM
Last Modification Date: 2024-10-26 @ 10:30 AM
Study NCT ID: NCT01288209
Status: COMPLETED
Last Update Posted: 2014-01-24
First Post: 2011-02-01

Brief Title: A Phase III Study of TMC435 in Genotype 1 Hepatitis C-infected Participants Who Failed to Respond to Previous IFN-based Therapy
Sponsor:
Organization: Janssen Pharmaceutical KK

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 106
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE3
Observational Models:
Time Perspective List:
Who Masked List: